A detailed history of Foundry Partners, LLC transactions in Accuray Inc stock. As of the latest transaction made, Foundry Partners, LLC holds 2,187,160 shares of ARAY stock, worth $4.24 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,187,160
Previous 1,445,260 51.33%
Holding current value
$4.24 Million
Previous $2.63 Million 49.66%
% of portfolio
0.2%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.41 - $2.49 $1.05 Million - $1.85 Million
741,900 Added 51.33%
2,187,160 $3.94 Million
Q2 2024

Aug 05, 2024

SELL
$1.49 - $2.43 $28,123 - $45,866
-18,875 Reduced 1.29%
1,445,260 $2.63 Million
Q1 2024

May 08, 2024

SELL
$2.37 - $2.94 $14,030 - $17,404
-5,920 Reduced 0.4%
1,464,135 $3.62 Million
Q4 2023

Feb 01, 2024

SELL
$2.44 - $3.08 $64,806 - $81,804
-26,560 Reduced 1.77%
1,470,055 $4.16 Million
Q3 2023

Nov 09, 2023

SELL
$2.63 - $4.26 $5,220 - $8,456
-1,985 Reduced 0.13%
1,496,615 $4.07 Million
Q2 2023

Jul 12, 2023

SELL
$2.7 - $3.97 $644,832 - $948,143
-238,827 Reduced 13.75%
1,498,600 $5.8 Million
Q1 2023

May 03, 2023

BUY
$2.06 - $3.18 $333,678 - $515,096
161,980 Added 10.28%
1,737,427 $5.16 Million
Q4 2022

Jan 30, 2023

BUY
$1.88 - $2.4 $819,881 - $1.05 Million
436,107 Added 38.28%
1,575,447 $3.29 Million
Q3 2022

Oct 21, 2022

BUY
$1.92 - $2.97 $637,257 - $985,757
331,905 Added 41.11%
1,139,340 $2.37 Million
Q1 2022

Apr 14, 2022

SELL
$3.16 - $4.81 $51,113 - $77,801
-16,175 Reduced 1.96%
807,435 $2.67 Million
Q4 2021

Jan 26, 2022

BUY
$3.72 - $5.88 $528,147 - $834,813
141,975 Added 20.83%
823,610 $3.93 Million
Q3 2021

Oct 14, 2021

BUY
$3.5 - $4.56 $2.39 Million - $3.11 Million
681,635 New
681,635 $2.69 Million

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $182M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.